IHH Healthcare Berhad (SGX:Q0F)
Singapore · Delayed Price · Currency is SGD 2.220
+0.120 (5.71%)
Sep 17, 2025, 4:41 PM SGT
IHH Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 24,927 | 24,383 | 20,935 | 17,989 | 17,132 | 13,405 |
Other Revenue | - | - | - | - | 86.06 | - |
| 24,927 | 24,383 | 20,935 | 17,989 | 17,218 | 13,405 | |
Revenue Growth (YoY) | 7.60% | 16.47% | 16.38% | 4.48% | 28.45% | -10.11% |
Cost of Revenue | 16,611 | 16,061 | 13,870 | 11,817 | 11,219 | 9,298 |
Gross Profit | 8,316 | 8,322 | 7,065 | 6,172 | 5,999 | 4,107 |
Selling, General & Admin | 124 | 123 | 113 | 87.96 | 80.65 | 66.92 |
Other Operating Expenses | 2,600 | 2,572 | 1,192 | 1,862 | 1,394 | 1,158 |
Operating Expenses | 4,593 | 4,492 | 2,915 | 3,394 | 2,870 | 2,683 |
Operating Income | 3,724 | 3,831 | 4,150 | 2,777 | 3,128 | 1,424 |
Interest Expense | -913 | -787 | -688 | -471.66 | -444.56 | -466.46 |
Interest & Investment Income | 135 | 107 | 87 | 77.59 | 49.08 | 69.14 |
Earnings From Equity Investments | 30 | 29 | 26 | 38.87 | 39.86 | 18.39 |
Currency Exchange Gain (Loss) | 99 | 142 | -194 | -144.19 | -604.97 | -436.77 |
Other Non Operating Income (Expenses) | 309 | 229 | 658 | 455.77 | 455.48 | 129.44 |
EBT Excluding Unusual Items | 3,384 | 3,551 | 4,039 | 2,734 | 2,623 | 737.92 |
Merger & Restructuring Charges | -0.5 | -0.5 | - | - | -1.27 | -6.32 |
Impairment of Goodwill | - | - | - | -150.07 | - | -396.51 |
Gain (Loss) on Sale of Investments | 6 | 6 | 2 | 0.99 | 0.93 | -0.09 |
Gain (Loss) on Sale of Assets | - | - | - | - | 14.98 | 10.02 |
Asset Writedown | 180 | 200 | 8 | -367.56 | -82.19 | -1.31 |
Other Unusual Items | -155 | - | - | - | - | 223.8 |
Pretax Income | 3,414 | 3,756 | 4,049 | 2,217 | 2,556 | 567.51 |
Income Tax Expense | 732 | 594 | 658 | 571.95 | 379.15 | 361.66 |
Earnings From Continuing Operations | 2,682 | 3,162 | 3,391 | 1,645 | 2,177 | 205.85 |
Minority Interest in Earnings | -459 | -505 | -439 | -96.74 | -314.06 | 83.04 |
Net Income | 2,223 | 2,657 | 2,952 | 1,548 | 1,863 | 288.88 |
Preferred Dividends & Other Adjustments | - | - | - | 52.21 | 88.3 | 89.84 |
Net Income to Common | 2,223 | 2,657 | 2,952 | 1,496 | 1,774 | 199.04 |
Net Income Growth | -16.14% | -9.99% | 90.65% | -16.87% | 544.74% | -47.62% |
Shares Outstanding (Basic) | 8,815 | 8,808 | 8,807 | 8,803 | 8,782 | 8,776 |
Shares Outstanding (Diluted) | 8,819 | 8,811 | 8,807 | 8,804 | 8,783 | 8,779 |
Shares Change (YoY) | 0.13% | 0.04% | 0.03% | 0.25% | 0.04% | 0.05% |
EPS (Basic) | 0.25 | 0.30 | 0.34 | 0.17 | 0.20 | 0.02 |
EPS (Diluted) | 0.25 | 0.30 | 0.34 | 0.17 | 0.20 | 0.02 |
EPS Growth | -16.19% | -10.02% | 97.28% | -15.89% | 790.65% | -57.05% |
Free Cash Flow | 1,068 | 1,156 | 1,888 | 1,999 | 2,504 | 1,571 |
Free Cash Flow Per Share | 0.12 | 0.13 | 0.21 | 0.23 | 0.28 | 0.18 |
Dividend Per Share | 0.105 | 0.100 | 0.090 | 0.070 | 0.060 | 0.040 |
Dividend Growth | 5.00% | 11.11% | 28.57% | 16.67% | 50.00% | - |
Gross Margin | 33.36% | 34.13% | 33.75% | 34.31% | 34.84% | 30.64% |
Operating Margin | 14.94% | 15.71% | 19.82% | 15.44% | 18.17% | 10.63% |
Profit Margin | 8.92% | 10.90% | 14.10% | 8.32% | 10.30% | 1.49% |
Free Cash Flow Margin | 4.29% | 4.74% | 9.02% | 11.11% | 14.55% | 11.72% |
EBITDA | 5,106 | 5,124 | 5,270 | 3,817 | 4,124 | 2,433 |
EBITDA Margin | 20.48% | 21.01% | 25.17% | 21.22% | 23.95% | 18.15% |
D&A For EBITDA | 1,382 | 1,293 | 1,120 | 1,040 | 995.92 | 1,009 |
EBIT | 3,724 | 3,831 | 4,150 | 2,777 | 3,128 | 1,424 |
EBIT Margin | 14.94% | 15.71% | 19.82% | 15.44% | 18.17% | 10.63% |
Effective Tax Rate | 21.44% | 15.82% | 16.25% | 25.80% | 14.84% | 63.73% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.